Recursion Pharmaceuticals (RXRX)
(Delayed Data from NSDQ)
$6.80 USD
-0.14 (-2.02%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $6.78 -0.02 (-0.29%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth B Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/14/24 |
---|---|
Current Quarter | -0.31 |
EPS Last Quarter | -0.40 |
Last EPS Surprise | -14.29% |
ABR | 2.63 |
Earnings ESP
|
-12.90% |
---|---|
Current Year | -1.58 |
Next Year | -1.44 |
EPS (TTM) | -1.62 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 30.31M | 12.29M | 70.63M | 62.08M |
# of Estimates | 5 | 4 | 5 | 5 |
High Estimate | 44.60M | 20.00M | 88.30M | 95.00M |
Low Estimate | 11.15M | 5.25M | 44.61M | 12.77M |
Year ago Sales | 10.53M | 10.89M | 44.58M | 70.63M |
Year over Year Growth Est. | 187.83% | 12.81% | 58.45% | -12.11% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.31 | -0.39 | -1.58 | -1.44 |
# of Estimates | 4 | 4 | 4 | 5 |
Most Recent Consensus | -0.30 | -0.48 | -1.57 | -1.52 |
High Estimate | -0.21 | -0.26 | -1.55 | -1.18 |
Low Estimate | -0.38 | -0.48 | -1.62 | -1.64 |
Year ago EPS | -0.43 | -0.40 | -1.58 | -1.58 |
Year over Year Growth Est. | 27.91% | 2.50% | 0.00% | 8.67% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 1 | 0 |
Up Last 60 Days | 2 | 0 | 1 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 1 |
Down Last 60 Days | 0 | 2 | 2 | 4 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.31 | -0.39 | -1.58 | -1.44 |
7 Days Ago | -0.31 | -0.39 | -1.58 | -1.44 |
30 Days Ago | -0.30 | -0.37 | -1.60 | -1.42 |
60 Days Ago | -0.33 | -0.32 | -1.56 | -1.36 |
90 Days Ago | -0.39 | -0.40 | -1.60 | -1.47 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.35 | -0.42 | -1.56 | -1.59 |
Zacks Consensus Estimate | -0.31 | -0.39 | -1.58 | -1.44 |
Earnings ESP | -12.90% | -9.09% | 0.95% | -10.57% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.40 | -0.39 | -0.40 | -0.43 | NA |
Estimate | -0.35 | -0.43 | -0.46 | -0.38 | NA |
Difference | -0.05 | 0.04 | 0.06 | -0.05 | 0.00 |
Surprise | -14.29% | 9.30% | 13.04% | -13.16% | -1.28% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more